Tilmanocept

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Name
Tilmanocept
Accession Number
DB15373
Type
Small Molecule
Groups
Investigational
Description

Tilmanocept is under investigation in clinical trial NCT03241446 (Pharmacokinetics and Dosimetry of Tc 99m Tilmanocept Following a Single Intravenous Dose Administration in Male and Female Subjects Diagnosed With Rheumatoid Arthritis (RA)).

Synonyms
Not Available
Categories
Not Available
UNII
MDU8BQ474H
CAS number
1185986-76-8
Weight
Not Available
Chemical Formula
Not Available
InChI Key
Not Available
InChI
Not Available
IUPAC Name
Not Available
SMILES
Not Available

Pharmacology

Indication
Not Available
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

References

General References
Not Available
External Links
Wikipedia
Technetium_(99mTc)_tilmanocept

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
1Active Not RecruitingDiagnosticHuman Immunodeficiency Virus (HIV) Infections / Kaposi s Sarcoma (KS)1
1CompletedDiagnosticNASH - Nonalcoholic Steatohepatitis / Nonalcoholic Steatohepatitis1
1CompletedDiagnosticRheumatoid Arthritis1
1RecruitingDiagnosticCentral Nervous System Neoplasms / Tumors of the Central Nervous System1
1TerminatedDiagnosticCarcinoma, Colorectal / Hepatic Metastases1
1TerminatedTreatmentEndometrial Cancer1
1WithdrawnDiagnosticRheumatoid Arthritis1
1, 2CompletedDiagnosticRheumatoid Arthritis1
2CompletedDiagnosticKaposi s Sarcoma (KS)1
2CompletedDiagnosticMelanoma / Rhabdomyosarcomas1
2Not Yet RecruitingDiagnosticRheumatoid Arthritis1
2RecruitingDiagnosticHead and Neck Squamous Cell Carcinoma (HNSCC)1
2RecruitingDiagnosticRheumatoid Arthritis1
2TerminatedDiagnosticUterine Cervical Neoplasms1
3TerminatedDiagnosticHead and Neck Squamous Cell Carcinoma (HNSCC)1
4RecruitingDiagnosticBreast Cancer / Sentinel Lymph Node Biopsy1
Not AvailableCompletedNot AvailableBreast Cancer1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
Not Available
Predicted ADMET features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
Not Available

Taxonomy

Classification
Not classified

Drug created on May 20, 2019 09:21 / Updated on March 01, 2020 22:06

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Logo pink
Stay in the know!
As part of our commitment to providing the most up-to-date drug information, we will be releasing #DrugBankUpdates with our newly added curated drug pages.
#DrugBankUpdates